COVID Vaccines: US FDA Should Play More Activist Role In Development Of Modified Formulations

Dictation
FDA's external experts want the agency, not manufacturers, to dictate the conversation on variants and new formulations for modified vaccines. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA Performance Tracker

More from Regulatory Trackers